<?xml version="1.0" encoding="UTF-8"?>
<p>To succeed, the financial model needs a minimum of 55% of all patients who are diagnosed with chronic HCV and HBV to start and adhere to treatment (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>). Initial data from the first 3 months of the programs show that only 23.0% of patients had started treatment, indicating that patient attrition in the cascade of care is currently too high to recover the upfront catalytic investment by program conclusion.
</p>
